Provided by Tiger Fintech (Singapore) Pte. Ltd.

Mind Medicine (MindMed) Inc.

6.15
-0.3100-4.80%
Post-market: 6.160.0110+0.18%19:32 EDT
Volume:946.65K
Turnover:5.86M
Market Cap:464.64M
PE:-3.99
High:6.53
Open:6.46
Low:6.03
Close:6.46
Loading ...

Company Profile

Company Name:
Mind Medicine (MindMed) Inc.
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
74
Office Location:
One World Trade Center,Suite 8500,New York,New York,United States
Zip Code:
10007
Fax:
- -
Introduction:
Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine for the treatment of core symptoms of autism spectrum disorder. The company also develops MM-110, an a3ß4 nicotinic cholinergic receptor antagonist that has completed phase 1 for the treatment of opioid withdrawal. The company is headquartered in New York, New York.